Sponsor

Sun Pharmaceutical Industries Limited

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Sun Pharmaceutical Industries Limited appears in 16 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials16
Recruiting shown3
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

16 shown
Study to Evaluate if Exposure to Drug is Impacted in Participants With Renal InsufficiencyNCT07385547 · lead sponsor · 2026-02-25
RECRUITING
Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes MellitusNCT07282743 · lead sponsor · 2026-01-20
RECRUITING
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.NCT05422911 · lead sponsor · 2022-08-31
RECRUITING
A Therapeutic Equivalence Study in Subjects With Primary Open Angle Glaucoma or Ocular HypertensionNCT05022004 · lead sponsor · 2021-12-20
COMPLETED
A Comparative Study of SPARC's SDP-133 Once Daily and Lumigan in Subjects With Open Angle Glaucoma or Ocular HypertensionNCT03927443 · lead sponsor · 2019-06-10
WITHDRAWN
A Study to Evaluate the Effect of of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base (Sun Pharmaceuticals Industries Limited)NCT03528577 · lead sponsor · 2018-09-22
COMPLETED
One-year, Open Extension to Evaluate the Treatment of Patients With Castration-Resistant Prostate Cancer With YONSA™NCT02962284 · lead sponsor · 2016-11-01
COMPLETED
A Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate CancerNCT02737332 · lead sponsor · 2016-03-21
COMPLETED
To Evaluate The Efficacy And Safety Of Sunpharma1505 Compared With Reference1505 In Subjects With Active Rheumatoid ArthritisNCT02534896 · lead sponsor · 2015-11-01
TERMINATED
Bio-equivalence Study Between SAPHRIS and AsenapineNCT01948024 · lead sponsor · 2013-07-01
COMPLETED
Safety and Efficacy of SPIL1033 in Subjects With Type 2 Diabetes MellitusNCT01406717 · lead sponsor · 2013-03-01
COMPLETED
Cardiovascular-Kidney-Metabolic Syndrome RegistryNCT07718789 · collaborator · 2026-07-24
NOT_YET_RECRUITING
Efficacy of Mirtazapine in Major Depressive Disorder With InsomniaNCT05978219 · collaborator · 2023-05-25
COMPLETED
Evaluating the Efficacy and Safety of Nilotinib BE in Subjects With Early Alzheimer's DiseaseNCT05143528 · collaborator · 2022-02-01
UNKNOWN
CEQUA for Sjogren's Syndrome Dry EyeNCT04835623 · collaborator · 2021-06-21
COMPLETED
Abiraterone Acetate in Combination With TildrakizumabNCT04458311 · collaborator · 2020-12-01
TERMINATED

Drugs studied in this sponsor's trials

11 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Sun Pharmaceutical Industries Limited as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
abiraterone acetate2
placebo2
apalutamide1
asenapine1
brinzolamide Ophthalmic Suspension1
cyclosporine 0.9 MG/ML Ophthalmic Solution1
enzalutamide1
Lumigan1

Sponsor roles

lead sponsor11
collaborator5
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.